Ropinirole Prolonged ReleaseIn Advanced Parkinson’s Disease

被引:0
|
作者
Juliane Weber
Gillian M. Keating
机构
[1] Wolters Kluwer Health ∣ Adis,
[2] Wolters Kluwer Health,undefined
来源
CNS Drugs | 2009年 / 23卷
关键词
Levodopa; Ropinirole; Rotigotine; Levodopa Dosage; ReQuip;
D O I
暂无
中图分类号
学科分类号
摘要
▴ Ropinirole prolonged release is a non-ergoline dopamine receptor agonist that is indicated for the treatment of Parkinson’s disease.
引用
收藏
页码:81 / 90
页数:9
相关论文
共 50 条
  • [21] ROPINIROLE PROLONGED RELEASE REDUCES NOCTURNAL SYMPTOMS IN PATIENTS WITH PARKINSON'S DISEASE
    Sethi, K.
    Chaudhuri, R.
    Giorgi, L.
    Statham, J.
    Stover, N.
    GERONTOLOGIST, 2009, 49 : 455 - 455
  • [22] Ropinirole 24-hour prolonged release in advanced Parkinson's disease: Relationship between treatment response and disease severity
    Sethi, K. D.
    Stocchi, F.
    Giorgi, L.
    MOVEMENT DISORDERS, 2007, 22 : S92 - S93
  • [23] Economic Evaluation of Ropinirole Prolonged Release for Treatment of Parkinson's Disease in The Netherlands
    van Boven, Job F. M.
    Novak, Annoesjka
    Driessen, Maurice T.
    Boersma, Cornelis
    Boomsma, Maarten M.
    Postma, Maarten J.
    DRUGS & AGING, 2014, 31 (03) : 193 - 201
  • [24] Effects of ropinirole prolonged-release on sleep disturbances in Parkinson's disease
    Dusek, P.
    Buskova, J.
    Roth, J.
    Jech, R.
    Ruzicka, E.
    MOVEMENT DISORDERS, 2009, 24 : S350 - S350
  • [25] Ropinirole prolonged release offers patients with advanced Parkinson's disease greater opportunity to reduce their daily "off" time than ropinirole immediate release
    Stocchi, F.
    Giorgi, L.
    Hunter, B.
    Statham, J.
    Schapira, A. H. V.
    MOVEMENT DISORDERS, 2009, 24 : S280 - S280
  • [26] The PREPARED Study: An Assessment of Symptom Control in Patients with Advanced Parkinson's Disease Receiving Treatment with Adjunctive Ropinirole Prolonged Release or Ropinirole Immediate Release
    Stocchi, Fabrizio
    Giorgi, Luigi
    Hunter, Brian
    Schapira, Anthony
    NEUROLOGY, 2009, 72 (11) : A413 - A413
  • [27] Prospective study on the use of ropinirole in patients with advanced Parkinson's disease
    Relja, M
    Telarovic, S
    MOVEMENT DISORDERS, 2004, 19 : S214 - S214
  • [28] Adjunctive ropinirole 24-hour prolonged release compared with ropinirole immediate release in patients with advanced Parkinson's disease (PD): the PREPARED study
    Stocchi, F.
    Hunter, B.
    Giorgi, L.
    Schapira, A. H. V.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 134 - 134
  • [29] Ropinirole Patch Versus Placebo, Ropinirole Extended-Release Tablet in Advanced Parkinson's Disease
    Hattori, Nobutaka
    Mochizuki, Hideki
    Hasegawa, Kazuko
    Nomoto, Masahiro
    Uchida, Eiji
    Terahara, Takaaki
    Okawa, Koji
    Fukuta, Hiroyuki
    MOVEMENT DISORDERS, 2020, 35 (09) : 1565 - 1573
  • [30] Ropinirole 24-hour prolonged release - Randomized, controlled study in advanced Parkinson disease
    Pahwa, R.
    Stacy, M. A.
    Factor, S. A.
    Lyons, K. E.
    Stocchi, F.
    Hersh, B. P.
    Elmer, L. W.
    Truong, D. D.
    Earl, N. L.
    NEUROLOGY, 2007, 68 (14) : 1108 - 1115